Humanistic burden of disease for patients with advanced melanoma in Canada.

about

Humanistic burden of disease for patients with advanced melanoma in Canada.

Item

http://www.wikidata.org/entity/Q47557075

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Humanistic burden of disease for patients with advanced melanoma in Canada.

@en

Humanistic burden of disease for patients with advanced melanoma in Canada.

@nl

type

Item

label

Humanistic burden of disease for patients with advanced melanoma in Canada.

@en

Humanistic burden of disease for patients with advanced melanoma in Canada.

@nl

prefLabel

Humanistic burden of disease for patients with advanced melanoma in Canada.

@en

Humanistic burden of disease for patients with advanced melanoma in Canada.

@nl

P1476

Humanistic burden of disease for patients with advanced melanoma in Canada.

@en

P2093

Andrew Lovley

http://www.w3.org/2001/XMLSchema#string

Angela Stroupe

http://www.w3.org/2001/XMLSchema#string

Bellinda L King-Kallimanis

http://www.w3.org/2001/XMLSchema#string

Kathryn Lasch

http://www.w3.org/2001/XMLSchema#string

Martha S Bayliss

http://www.w3.org/2001/XMLSchema#string

Michelle K White

http://www.w3.org/2001/XMLSchema#string

Winson Y Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

Final version of 2009 AJCC melanoma staging and classification

Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.

A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis

The genetics of hereditary melanoma and nevi. 1998 update.

Measuring outcomes in oncology treatment: the importance of patient-centered outcomes

Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.

P2888

s00520-017-4025-9

P304

1985-1991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-4025-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29322243

http://www.w3.org/2001/XMLSchema#string

P932

5919988

http://www.w3.org/2001/XMLSchema#string